Skip to main content

€1.144 billion secured by startups and scaleups in five years

The most significant growth in the BioRegion has been in investment. While the amount secured by startups and scaleups in the BioRegion in 2021 (€238 million) doubled that of 2019, before the pandemic (€123 million), in 2022 investment once again saw an increase x2, reaching €445 million, with the first megaround in the sector (€122 million in medtech firm Impress).

Foreign Direct Investment (FDI) also increased significantly (x7) between 2018 and 2022, with a total of €689 million in direct investment, generating over 2,900 jobs. According to the prestigious report published by the Financial Times, the FDI European Cities and Regions of the Future 2022/2023, Catalonia and Barcelona stand out as the region and city with the best strategy for attracting investment in Europe.

The BioRegion has over 60 investors and growing participation from international venture capital funds.

Read the FDI European Cities and Regions of the Future 2022/2023 report
FDI and funds for startups

Growth in all investments

Employment and turnover

247,600 jobs and nearly €40 billion in turnover

One quarter of employment generated by the life sciences and healthcare sector (59,598 jobs) is in industry, a figure that is up 12% since 2017. Furthermore, 188,000 people work at healthcare institutions that provide diagnostic and medical treatments. The sector as a whole represents 7% of all employment in Catalonia.

The industry generates 56% of turnover in the sector (€21.97 billion in 2021), which has also increased steadily over the past 5 years (+20%). Nearly half of this revenue is from pharmaceutical companies (€10.37 billion) and, although with much lower turnover, the digital health (+16%) and suppliers (+37%) segments saw noteworthy growth in 2021.

Check out the 2022 BioRegion Report

L’ocupació del sector de CatalunyaResearch staff working on a study
Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.